Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open Label, Comparative Multicenter Study Of Voriconazole Versus Conventional Amphotericin B Followed By Fluconazole In The Treatment Of Candidaemia In Non Neutropenic Subjects.

NCT00163111 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00163111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00163111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open Label, Comparative Multicenter Study Of Voriconazole Versus Conventional Amphotericin B Followed By Fluconazole In The Treatment Of Candidaemia In Non Neutropenic Subjects.
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
September 30, 1998
Completion date
May 31, 2003
Enrollment
412 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

candidiasis